指南与共识炎症性肠病

预测儿童克罗恩病结局以优化管理:儿童炎症性肠病-Ahead项目的系统综述与共识声明

Predicting Outcomes in Pediatric Crohn's Disease for Management Optimization: Systematic Review and Consensus Statements From the Pediatric Inflammatory Bowel Disease-Ahead Program.
指南 / 共识 · Gastroenterology · 2020-09-23

该共识通过调查202位儿童克罗恩病专家确定需避免的不良结局,系统综述并荟萃分析预后因素,经多轮会议达成27条共识,涉及手术、并发症、慢性活动性疾病和住院的预测因素,为制定治疗算法和未来研究提供依据。

要点

  • 共识涵盖手术、并发症、慢性活动性疾病和住院四类结局的预后因素
  • 手术预后因素包括青春期诊断、生长障碍、NOD2/CARD15多态性、疾病行为和抗酿酒酵母抗体阳性
  • 孤立性结肠病变与较少手术相关;男性、低龄起病、小肠病变、活动性疾病和诊断延迟可能与生长障碍相关

核心结论

  • 这些基于证据的共识声明为儿童克罗恩病不良结局的预测因素提供了见解,在制定治疗算法和规划未来研究时有价值。
  • 需要有针对性的纵向研究来进一步明确儿童克罗恩病的预后因素,并评估根据个体患者风险定制的治疗算法的影响。

研究设计与样本

  • 对202位儿童克罗恩病专家进行调查,确定并优先排序需避免的不良结局。
  • 对文献进行系统综述,并在可能时进行荟萃分析,以识别研究这些结局预测因素的临床研究。
  • 举行多次国家和国际面对面会议,基于已发表的证据起草共识声明。

主要发现

  • 达成27条关于手术、并发症、慢性活动性儿童克罗恩病和住院预后因素的共识声明。
  • 手术的预后因素包括青春期诊断克罗恩病、生长障碍、NOD2/CARD15多态性、疾病行为和抗酿酒酵母抗体阳性。
  • 孤立性结肠病变与较少手术相关。
  • 就诊时年龄较大、小肠疾病、血清学(抗酿酒酵母抗体、抗鞭毛蛋白抗体和OmpC)、NOD2/CARD15多态性、肛周疾病和种族是穿透性疾病(B3)和/或狭窄性疾病(B2)的危险因素。
  • 男性、起病年龄小、小肠疾病、更活跃的疾病和诊断延迟可能与生长障碍相关;营养不良和较高的疾病活动度与骨密度降低相关。

关键数值与推荐

  • 共识达成27条声明,涉及手术、并发症、慢性活动性儿童克罗恩病和住院的预后因素。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 需要有针对性的纵向研究来进一步明确儿童克罗恩病的预后因素,并评估根据个体患者风险定制的治疗算法的影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: A better understanding of prognostic factors within the heterogeneous spectrum of pediatric Crohn's disease (CD) should improve patient management and reduce complications. We aimed to identify evidence-based predictors of outcomes with the goal of optimizing individual patient management. METHODS: A survey of 202 experts in pediatric CD identified and prioritized adverse outcomes to be avoided. A systematic review of the literature with meta-analysis, when possible, was performed to identify clinical studies that investigated predictors of these outcomes. Multiple national and international face-to-face meetings were held to draft consensus statements based on the published evidence. RESULTS: Consensus was reached on 27 statements regarding prognostic factors for surgery, complications, chronically active pediatric CD, and hospitalization. Prognostic factors for surgery included CD diagnosis during adolescence, growth impairment, NOD2/CARD15 polymorphisms, disease behavior, and positive anti-Saccharomyces cerevisiae antibody status. Isolated colonic disease was associated with fewer surgeries. Older age at presentation, small bowel disease, serology (anti-Saccharomyces cerevisiae antibody, antiflagellin, and OmpC), NOD2/CARD15 polymorphisms, perianal disease, and ethnicity were risk factors for penetrating (B3) and/or stenotic disease (B2). Male sex, young age at onset, small bowel disease, more active disease, and diagnostic delay may be associated with growth impairment. Malnutrition and higher disease activity were associated with reduced bone density. CONCLUSIONS: These evidence-based consensus statements offer insight into predictors of poor outcomes in pediatric CD and are valuable when developing treatment algorithms and planning future studies. Targeted longitudinal studies are needed to further characterize prognostic factors in pediatric CD and to evaluate the impact of treatment algorithms tailored to individual patient risk.

来源:Gastroenterology,查看原文。版权归原作者所有。

引用

  1. Ricciuto A, Aardoom M, Orlanski-Meyer E, et al. Predicting Outcomes in Pediatric Crohn's Disease for Management Optimization: Systematic Review and Consensus Statements From the Pediatric Inflammatory Bowel Disease-Ahead Program. Gastroenterology. 2020. PMID: 32979356. doi:10.1053/j.gastro.2020.07.065

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。